China National Medicines Corporation Ltd. (SHA:600511)

SHA:600511 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	50,500	49,592	45,436	46,442	40,336
Other Revenue	97.79	103.99	62.95	26.26	43.04
Revenue	50,597	49,696	45,499	46,469	40,379
Revenue Growth (YoY)	1.81%	9.22%	-2.09%	15.08%	-9.55%
Cost of Revenue	47,003	45,704	41,681	42,848	37,242
Gross Profit	3,594	3,992	3,817	3,621	3,136
Selling, General & Admin	1,267	1,430	1,392	1,355	1,404
Research & Development	73.71	71.2	67	55.75	51.87
Other Operating Expenses	126.25	109.69	46.91	120.86	105.54
Operating Expenses	1,489	1,620	1,498	1,566	1,571
Operating Income	2,105	2,372	2,319	2,055	1,566
Interest Expense	-33.66	-31.57	-26.88	-43.71	-56.81
Interest & Investment Income	620.95	525.32	362.42	354.09	279.16
Currency Exchange Gain (Loss)	1.94	0.55	-1.65	2.71	1.57
Other Non Operating Income (Expenses)	-7.04	-9.23	-43.29	-18	2.24
EBT Excluding Unusual Items	2,687	2,857	2,609	2,350	1,792
Gain (Loss) on Sale of Investments	-18.2	10.82	-	-	-
Gain (Loss) on Sale of Assets	-0.19	0.08	1.68	-0.07	0.07
Other Unusual Items	-14.9	62.81	76.9	95.08	125.4
Pretax Income	2,654	2,931	2,688	2,445	1,917
Income Tax Expense	523.83	596.42	559.18	516.3	408.09
Earnings From Continuing Operations	2,130	2,334	2,129	1,929	1,509
Minority Interest in Earnings	-129.65	-188.47	-164.65	-174.42	-126.56
Net Income	2,000	2,146	1,964	1,754	1,383
Net Income to Common	2,000	2,146	1,964	1,754	1,383
Net Income Growth	-6.80%	9.26%	11.97%	26.86%	-13.79%
Shares Outstanding (Basic)	755	754	755	755	754
Shares Outstanding (Diluted)	755	754	755	755	754
Shares Change (YoY)	0.00%	-0.00%	-	0.00%	-0.98%
EPS (Basic)	2.65	2.84	2.60	2.32	1.83
EPS (Diluted)	2.65	2.84	2.60	2.32	1.83
EPS Growth	-6.80%	9.27%	11.97%	26.86%	-12.94%
Free Cash Flow	1,528	2,582	2,265	1,862	1,233
Free Cash Flow Per Share	2.03	3.42	3.00	2.47	1.63
Dividend Per Share	0.800	0.854	0.782	0.700	0.550
Dividend Growth	-6.32%	9.21%	11.71%	27.27%	-13.79%
Gross Margin	7.10%	8.03%	8.39%	7.79%	7.77%
Operating Margin	4.16%	4.77%	5.10%	4.42%	3.88%
Profit Margin	3.95%	4.32%	4.32%	3.77%	3.42%
Free Cash Flow Margin	3.02%	5.20%	4.98%	4.01%	3.05%
EBITDA	2,215	2,485	2,423	2,155	1,669
EBITDA Margin	4.38%	5.00%	5.32%	4.64%	4.13%
D&A For EBITDA	110.03	113.09	103.86	100.1	103.46
EBIT	2,105	2,372	2,319	2,055	1,566
EBIT Margin	4.16%	4.77%	5.10%	4.42%	3.88%
Effective Tax Rate	19.74%	20.35%	20.80%	21.12%	21.28%
Revenue as Reported	50,597	49,696	45,499	46,469	40,379
Advertising Expenses	4.74	6.7	3.25	2.25	3.2

Source: S&P Global Market Intelligence. Standard template. Financial Sources.